Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Brexit rebels win vote on European Medicines Agency alignment

EMA membership will be a key negotiating aim; Sir John Bell sees independent MHRA post-Brexit

- PMLiVE

NHS England to Vertex: come clean on Orkambi offer

Vertex has offered Orkambi at an almost 90% discount to the NHS, according to BioCentury

Data Visualisation

Last week’s Thirsty Thursday was all about data visualisation and was hosted by Katherine Mantell, Managing Director of Leading Edge – part of the Lucid family of companies.Katherine started the session with...

Lucid Group Communications Limited

The True Potential of Mobile Health Tech

In a recent edition of PME, Dennis O’Brien, Lucid CEO and co-founder, discusses the potential of mobile health in improving patient outcomes – a goal that is at the heart...

Lucid Group Communications Limited

- PMLiVE

Novartis follows Pfizer and freezes US prices this year

And still expects revenues to come in at the high end of expectations for 2018

- PMLiVE

Precision Medicine Group acquires Ethos

The services company will boost PMG's capabilities in complex data interpretation

- PMLiVE

Pfizer enters late-stage haemophilia B gene therapy trial

Race is on to free patients of regular injections

- PMLiVE

Porterhouse Medical strengthens the team with three new members.

After an intensive period of recruitment, the team at Porterhouse Medical is delighted to welcome three new arrivals to our UK offices in Reading.Joining our scientific services team as associate...

Porterhouse Medical Group

Advocacy Programme Development

Developing advocacy in the pharmaceutical industry.

The importance of advocacy programmes

Porterhouse Medical Group

Roche Basel Switzerland

Roche’s Tamiflu successor hits the mark in complicated flu

Baloxavir marboxil met its primary objective and cut flu-related complications

- PMLiVE

J&J’s Invokana aces diabetic kidney disease trial, setting up filings

It could be the first new drug in 15 years to slow kidney damage development

Novartis launch NET cancer community app

Galaxies of Hope aims to provide support to cancer patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links